BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving research platform. New compounds and evidence are added continuously.
B

POT1

MOLECULAR TARGET

POT1

24 compounds

POT1 (POT1) is targeted by 24 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting POT1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1cnidium monnieri1.001
2saposhnikovia divaricata1.001
3albizia julibrissin0.501
4apis mellifera0.501
5arctium lappa0.501
6bombyx mori0.501
7citrus reticulata0.501
8coix lacryma0.501
9epimedium brevicornum0.501
10eriobotrya japonica0.501
11euryale ferox0.501
12Ginkgo biloba0.501
13glycine max0.501
14Juglans0.501
15lilium lancifolium0.501
16mentha haplocalyx0.501
17morus alba0.501
18perilla frutescens0.501
19peucedanum praeruptorum0.501
20pinellia ternata0.501
21poria cocos0.501
22Portulaca0.501
23stemona sessilifolia0.501
24trichosanthes kirilowii0.501

About POT1 as a Drug Target

POT1 (POT1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 24 compounds with documented POT1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

POT1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.